Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Palonosetron Versus Ondansetron for PONV Prevention in Patients Undergoing Endoscopic Retrograde Cholangio-Pancreatography ERCP: A Prospective Randomized Controlled Study

NCT04576390 is registered in ClinicalTrials.gov with Theodor Bilharz Research Institute as lead sponsor.

NCT NCT04576390
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04576390 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Palonosetron Versus Ondansetron for PONV Prevention in Patients Undergoing Endoscopic Retrograde Cholangio-Pancreatography ERCP: A Prospective Randomized Controlled Study
Lead sponsor
Theodor Bilharz Research Institute
Phase
Phase 4
Overall status
Unknown status
Start date
October 24, 2020
Completion date
May 25, 2021
Enrollment
90 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

antiemetic, postoperative nausea and vomiting